US2016095343A1PendingUtilityA1

Synbiotic Product

Assignee: TATE & LYLE INGREDIENTSPriority: Aug 25, 2010Filed: Dec 11, 2015Published: Apr 7, 2016
Est. expiryAug 25, 2030(~4.1 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 31/04A23K 20/163A61K 35/742A23L 33/21A23K 10/40A23L 33/125A23L 33/135A61P 1/00A23V 2002/00A23K 10/00A23K 10/18A23K 1/009A23L 1/308A23L 1/3014A23K 1/1643A61K 35/74
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a synbiotic product composition comprising a blend or mixture of a prebiotic carbohydrate and a probiotic spore-forming Bacillus bacteria. Examples of prebiotic carbohydrates useful in synbiotic product include arabinoxylan, arabinoxylan oligosaccharides, xylose, soluble fiber dextrin, soluble corn fiber, and polydextrose. The present invention also relates to human foodstuffs and animal feed comprising such synbiotic products and methods of increasing the titer of spore-forming bacteria in the intestinal tracts of mammals by administration of synbiotic products.

Claims

exact text as granted — not AI-modified
1 . A synbiotic product comprising at least one prebiotic carbohydrate selected from the group consisting of arabinoxylan, arabinoxylan oligosaccharides, xylose, soluble fiber dextrin, soluble corn fiber, polydextrose, and mixtures thereof, and at least one probiotic spore-forming  Bacillus  bacteria. 
     
     
         2 . The synbiotic product of  claim 1  wherein the prebiotic carbohydrate is selected from the group consisting of arabinoxylan, arabinoxylan oligosaccharides, xylose, and mixtures thereof. 
     
     
         3 . The synbiotic product of  claim 1  wherein the spore-forming  Bacillus  bacteria is selected from the group consisting of  B. subtilis, B. coagulans, B. licheniformis, B. clausii, B. pumilis , and mixtures thereof. 
     
     
         4 . A food product comprising a synbiotic product of  claim 1 . 
     
     
         5 . A method of increasing the titer of a spore-forming  Bacillus  bacteria in the intestinal tract of a mammal, the method comprising administering to the mammal an effective amount of the synbiotic product of  claim 1 . 
     
     
         6 . The method of  claim 5  wherein the synbiotic product is administered such that the amount of prebiotic carbohydrate is from about 1 g to about 25 g in any one day and the amount of probiotic spore-forming  Bacillus  bacteria is from about 10 4  CFU to about 10 10  CFU in any one day. 
     
     
         7 . (canceled) 
     
     
         8 . The method of  claim 5  wherein the synbiotic product is administered daily. 
     
     
         9 . The method of  claim 5  wherein the synbiotic product is administered through the consumption of a food product comprising the synbiotic product. 
     
     
         10 . (canceled) 
     
     
         11 . The method of  claim 9  wherein the food product consumed is an animal feed and the mammal is a non-human mammal. 
     
     
         12 . (canceled) 
     
     
         13 . (canceled) 
     
     
         14 . The method of  claim 11  wherein antibiotics are not administered to the non-human mammal. 
     
     
         15 . A synbiotic product comprising a prebiotic carbohydrate component and a probiotic spore component, wherein the prebiotic carbohydrate component comprises at least one prebiotic carbohydrate selected from the group consisting of arabinoxylan, arabinoxylan oligosaccharides, xylose, soluble fiber dextrin, soluble corn fiber, polydextrose, and mixtures thereof and the probiotic spore component comprises at least one probiotic spore-forming  Bacillus  bacteria. 
     
     
         16 . The synbiotic product of  claim 15  wherein the prebiotic carbohydrate is selected from the group consisting of arabinoxylan, arabinoxylan oligosaccharides, xylose, and mixtures thereof. 
     
     
         17 . The synbiotic product of  claim 15  wherein the spore-forming  Bacillus  bacteria is selected from the group consisting of  B. subtilis, B. coagulans, B. licheniformis, B. clausii, B. pumilis , and mixtures thereof. 
     
     
         18 . The synbiotic product of  claim 15  wherein the probiotic spore component comprises up to about 10 11  viable spores per gram dry weight. 
     
     
         19 . (canceled) 
     
     
         20 . The synbiotic product of  claim 15  wherein the synbiotic product comprises at least about 10 5  viable probiotic spores per gram dry weight. 
     
     
         21 . (canceled) 
     
     
         22 . A food product comprising a synbiotic product of  claim 15 . 
     
     
         23 . A method of increasing the titer of a spore-forming  Bacillus  bacteria in the intestinal tract of a mammal, the method comprising administering to the mammal an effective amount of the synbiotic product of  claim 15 . 
     
     
         24 . The method of  claim 23  wherein the synbiotic product is administered such that the amount of prebiotic carbohydrate is from about 1 g to about 25 g in any one day and the amount of probiotic spore-forming  Bacillus  bacteria is from about 10 4  CFU to about 10 10  CFU in any one day. 
     
     
         25 . (canceled) 
     
     
         26 . The method of  claim 23  wherein the synbiotic product is administered daily. 
     
     
         27 . The method of  claim 23  wherein the synbiotic product is administered through the consumption of a food product comprising the synbiotic product. 
     
     
         28 - 32 . (canceled)

Join the waitlist — get patent alerts

Track US2016095343A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.